PHARMAZEUTISCHE FORMULIERUNG
European patent · EP4580606 · In force
Register entry
- Publication number
- EP4580606
- Application number
- EP23764853
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 30, 2023
- Published
- Jul 9, 2025
- Granted
- May 27, 2026
- Protection ends at the latest
- Aug 29, 2043
- Next annual fee due
- Aug 31, 2026
- IPC classes
- A61K 9/20 (2006.01)A61K 9/28 (2006.01)A61K 31/519 (2006.01)A61P 9/00 (2006.01)
- Priority
- WO PCT/CN2022/116379 31.08.2022
- PCT application
- PCT/EP2023/073764 30.08.2023
- PCT publication
- WO2024/047094 07.03.2024
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 4, 2026
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach, 8027 Zürich
Published in Swissreg on 04.09.2026
- May 27, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 27.05.2026
Parties
Inventor
DENG, Wanding
Shanghai 201203, CN
FAN, Ying
Shanghai 201203, CN
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.